NCT02599376

Brief Summary

Obesity has become one of the most common risk factors in obstetric practice with serious anaesthetic implications. Obese pregnants have limited physiological reserves and cardiovascular co- morbidities when compared to non-obese pregnant women. Spinal anaesthesia is the anaesthetic technique of choice for caesarean section. The haemodynamic changes associated with spinal anaesthesia pose the greatest hazard to the mother and the foetus and are exaggerated in obese pregnant women. However differences in the changes in haemodynamic variables such as cardiac output (CO), stroke volume (SV) and systemic vascular resistance (SVR) between obese and non-obese pregnant women having caesarean section (CS) under spinal anaesthesia have not been studied before. This study compares the haemodynamic changes after spinal anaesthesia for CS in non-obese and obese parturients in a single centre, prospective case control study, using LiDCOrapidV2. This LiDCOrapidV2 device is a noninvasive method of measuring haemodynamic variables. It is a single centre, prospective, case control study. The primary outcome compares the differences and variability in CO, SV and SVR between obese and non-obese parturients. The secondary outcomes include comparison of the correlation between changes in blood pressure (BP) and CO in each patient and the difference in BP between conventional intermittent oscillometric device and continuous LiDCORapidV2in each patient with a view to assess the need for measurement of cardiac output in obstetric anaesthesia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2014

Completed
11 months until next milestone

First Posted

Study publicly available on registry

November 6, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

September 8, 2016

Status Verified

September 1, 2016

Enrollment Period

1.7 years

First QC Date

December 15, 2014

Last Update Submit

September 7, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in the variation of cardiac output (CO) from baseline values between obese and non-obese parturients after spinal anaesthesia.

    The change in cardiac output from baseline measured as milliliters/minute at predetermined intervals after spinal anaesthesia will be recorded in each group. The mean value of this change in each group will be compared for each recording and the difference in the change between the two groups will be reported.

    18 months

Secondary Outcomes (1)

  • Mean difference in the amount of vasopressors infused in millilitres/hour between non-obese and obese pregnant women.

    12 months

Study Arms (2)

BMI less than 30

ACTIVE COMPARATOR

The drop in cardiac output after spinal anaesthesia for LSCS at various intervals with LiDCORapid

Device: LiDCOrapid

BMI more than 40

EXPERIMENTAL

The drop in cardiac output after spinal anaesthesia for LSCS at various intervals with LiDCORapid

Device: LiDCOrapid

Interventions

Cardiac output will be non invasively monitored by using 2 cuffs on fingers.

BMI less than 30BMI more than 40

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant patients with BMI of less than 30 undergoing elective CS.
  • Obese pregnant patients with BMI of more than 35 undergoing elective CS

You may not qualify if:

  • Patients with other comorbidities like pre-eclampsia, eclampsia, essential hypertension, respiratory disease and compromised renal function.
  • Patients on long-term medication.
  • Patients having CS under epidural.
  • Patients having general anaesthesia.
  • Patients on antihypertensive medication.
  • Patients with BMI of 31-34.
  • Patients less than 36 weeks of gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aberdeen Maternity Hospital

Aberdeen, Aberdeen, AB25 2ZN, United Kingdom

Location

MeSH Terms

Conditions

Cardiac Output, Low

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Manisha Kumar, FRCA

    NHS Grampian

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2014

First Posted

November 6, 2015

Study Start

December 1, 2014

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

September 8, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations